SNHG16 and neoplasm: Notably, high SNHG16 expression was significantly correlated with larger tumor size (OR = 6.36, 95% CI 2.43–16.60, P = 0.0002), poor clinical stage (OR = 2.91, 95% CI 1.60–5.28, P = 0.005), LNM (OR = 4.42, 95% CI 2.66–7.35, P = 0.0001) and DM (OR = 3.86, 95% CI 1.92–7.77, P = 0.002).